
Daglupa 5mg Tablet
Marketer
Elsker lifescience Pvt. Ltd.
Salt Composition
Dapagliflozin (5mg)
Overview Daglupa 5mg Tablet
Glucodia 5mg tablets are indicated for managing type 2 diabetes, either independently or as part of a multi-drug regimen. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Glucodia 5mg may be administered with or without food, but consistent daily timing is recommended; dosage is determined by your physician. Discontinuation requires medical consultation, as abrupt cessation can elevate blood sugar, potentially leading to serious consequences such as renal impairment and visual disturbances. This medication forms one component of a comprehensive diabetes management plan, incorporating dietary adjustments, physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections; it can also induce fluid loss, necessitating increased fluid intake to prevent dehydration. Practicing good hygiene helps reduce the likelihood of genital fungal infections. Prior to commencing treatment, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before using Glucodia 5mg. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential throughout therapy.
Primary Ingredients of Daglupa 5mg Tablet
There is no text provided to rephrase.
Uses of Daglupa 5mg Tablet
Managing type 2 diabetes
Major Benefits of Daglupa 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Daglupa 5mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Daglupa 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Daglupa 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Daglupa Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Daglupa 5mg Tablet works:
Glucodown 5mg tablets help manage diabetes by facilitating the excretion of excess glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Daglupa 5mg tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Daglupa 5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
It's likely unsafe to breastfeed while taking Daglupa 5mg tablets. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Daglupa 5mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Daglupa 5mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Daglupa 5mg Tablet :
Should you forget a Daglupa 5mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daglupa 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
